Grünenthal Group
Dr. Kai Strothmann has a wealth of experience in the pharmaceutical and healthcare industries. Dr. Kai started at Schering AG as an International Product Manager and later held the position of Global Brand Manager. Moving on to DWS Investments, they served as a Portfolio Manager focused on the Pharma & Biotechnology sector. At Fresenius Medical Care, they worked their way up from Portfolio Manager to Director of Portfolio & Project Management. Currently, Dr. Strothmann is the VP of Global Portfolio Development at Die Grünenthal Gruppe, leading Early Products & Commercial Opportunities.
Dr. Kai Strothmann completed their Pharmacist degree at the University of Münster from 1991 to 1996. Dr. Kai then pursued a Dr. rer. nat. degree in Pharmacology at the same university from 1998 to 2001. Additionally, they served as a Post-doctoral fellow in Pharmacology at the Institute of Reproductive Medicine of the University Hospital Münster from 1998 to 2002. There is also a mention of C.E.L. for Pharma, but no specific degree or field of study is provided.
This person is not in the org chart
This person is not in any teams
Grünenthal Group
5 followers
Grünenthal is a global leader in pain management and related diseases. As a science-based privately-owned pharmaceutical company, they have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide.